Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma

NCT03789240 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

33

Enrollment

NIH

Sponsor class

Conditions

Follicular Lymphoma
Non-Hodgkin's Lymphoma
NHL

Interventions

BIOLOGICAL: Rituximab
DRUG: Copanlisib
PROCEDURE: Bone Marrow Aspiration/Biopsy
DIAGNOSTIC_TEST: CT Scans
DIAGNOSTIC_TEST: 18F-FDG-PET/CT Scan15
DIAGNOSTIC_TEST: Electrocardigram

Sponsor

National Cancer Institute (NCI)